About OnQuality
OnQuality is a Healthcare company based in Shanghai (China) founded in 2018 by Shiyi Zhang. Therapeutics for skin cancers and related reactions are developed. OnQuality has raised $20 million across 1 funding round from investors including Shiyu Capital, Matrix Partners China and BioTrack Capital. Its chief executive, as recorded, is Michael McCullar. OnQuality offers products and services including Cancer Supportive Care Treatments. Its focus areas include Life Sciences, Oncology, Drugs and Skin Cancer. Its legal entity is OnQuality Pharmaceuticals LLC.
Company details
OnQuality was founded in 2018 in Shanghai, China, within the biotechnology sector. Focus is placed on developing therapeutics targeting skin cancers and associated adverse reactions. The product pipeline includes OQL011 for VEGFR inhibitor-induced hand-foot skin reactions, OQL023 for skin rashes, and OQL033 for chemotherapy-induced hand-foot syndrome. Operations center on advancing these treatments for dermatological conditions in oncology.
- Headquarters Shanghai, China
- Founders Shiyi Zhang
- SectorsHealthcare
- Email••••••••
- Website onqualityrx.com
- Social LinkedIn X
- Legal Name Onquality Pharmaceuticals Llc
- Total Equity Funding$20M (USD)
in 1 rounds
- Latest Funding Round$20M (USD), Series A
Mar 2021
- InvestorsShiyu Capital
& 5 more
Products & Services of OnQuality
OnQuality offers a comprehensive portfolio of products and services, including Cancer Supportive Care Treatments.
Treatments to alleviate side effects of cancer drugs for better patient outcomes.
Funding Insights of OnQuality
OnQuality has successfully raised a total of $20M through 1 strategic funding round. The most recent funding activity was a Series A round of $20 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $20M
- Total Rounds 1
- Last Round Series A — $20M
- First Round $20M
(Mar 2021)
- Investors Count 6
All 1 funding rounds of OnQuality with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | $20M | Series A | – | – |
6 investors in total: 6 institutional.
Investors in OnQuality
OnQuality has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Shiyu Capital, Matrix Partners China and BioTrack Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Shiyu Capital is engaged in equity investment and asset allocation. | shiyucapital.com | Beijing, China | ||
Multiple sectors are invested in by this venture capital firm. | matrixpartners.com.cn | Chaoyang, China | ||
| biotrackcapital.com | ||||
Early-stage tech investments are targeted in China and the US. | sinovationventures.com | Beijing, China | ||
Tech focused VC firm investing in early stage companies in the US & China | freesvc.com | Beijing, China | ||
Venture capital investments are provided by CASH Capital in technology sectors. | 2011 | cashcapital.cn | Beijing, China |
Investor details for OnQuality
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of OnQuality
6 people are tracked at OnQuality (5 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Shiyi Zhang | Founder | Leadership |
Michael McCullar | CEO | Leadership |
家虎 吴 | Executive Director | Leadership |
HONG TANG, MD, FACP | President, OnQuality Pharmaceuticals (USA), LLC | Leadership |
Jie Luo | Co-Founder | Leadership |
María Escolano Becciu | Project Manager, CMC | Team |
Complete people profiles for OnQuality
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of OnQuality
2 dated milestones of OnQuality across 3 years, from founding to its latest funding, stage changes and deals.
- Founded OnQuality is founded.
- Funding First funding round of $20.0M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Onquality
Complete news archive for OnQuality
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OnQuality
OnQuality was founded in 2018 and raised its 1st funding round 3 years after it was founded.
OnQuality is headquartered in Shanghai, China.
Michael McCullar is the CEO of OnQuality, as recorded in our data.
OnQuality is a funded company, having raised a total of $20M across 1 funding round to date. The company's 1st funding round was a Series A of $20M, raised on Mar 2021.
OnQuality was founded in 2018 in Shanghai, China, within the biotechnology sector. Focus is placed on developing therapeutics targeting skin cancers and associated adverse reactions. The product pipeline includes OQL011 for VEGFR inhibitor-induced hand-foot skin reactions, OQL023 for skin rashes, and OQL033 for chemotherapy-induced hand-foot syndrome. Operations center on advancing these treatments for dermatological conditions in oncology.
OnQuality offers Cancer Supportive Care Treatments.
OnQuality has 6 investors. Key investors include Shiyu Capital, Matrix Partners China, BioTrack Capital, Sinovation Ventures, and Frees Fund.
OnQuality operates through Onquality Pharmaceuticals Llc.